Literature DB >> 20054096

The contributions of Louis I Woolf to the treatment, early diagnosis and understanding of phenylketonuria.

J R Alonso-Fernández1, C Colón.   

Abstract

Early diagnosis of phenylketonuria (PKU) became a goal worth pursuing following demonstration of the efficacy of the dietary treatment conceived by Louis I Woolf. This paper narrates the history of this treatment, describes Woolf's role in the establishment of neonatal PKU screening and surveys his other contributions to our understanding of this condition. If Woolf, Centerwall, Baird and Berry had waited until all the scientific evidence about PKU that is now at our disposal had been brought to light, there would still be no neonatal screening programmes.

Entities:  

Mesh:

Year:  2009        PMID: 20054096     DOI: 10.1258/jms.2009.009062

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  3 in total

Review 1.  Protein Substitutes in PKU; Their Historical Evolution.

Authors:  Anne Daly; Sharon Evans; Alex Pinto; Catherine Ashmore; Anita MacDonald
Journal:  Nutrients       Date:  2021-02-02       Impact factor: 5.717

2.  Pregnanetriolone in paper-borne urine for neonatal screening for 21-hydroxylase deficiency: The place of urine in neonatal screening.

Authors:  José Ramón Alonso-Fernández
Journal:  Mol Genet Metab Rep       Date:  2016-08-18

3.  Dr. Louis Isaac Woolf: At the Forefront of Newborn Screening and the Diet to Treat Phenylketonuria-Biography to Mark His 100th Birthday.

Authors:  José Ramón Alonso-Fernández
Journal:  Int J Neonatal Screen       Date:  2020-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.